ciprofloxacin and 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide

ciprofloxacin has been researched along with 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, J; Wang, Z; Zhang, CY	1

Other Studies

1 other study(ies) available for ciprofloxacin and 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide

Article	Year
Bioresponsive Nanoparticles Targeted to Infectious Microenvironments for Sepsis Management. Advanced materials (Deerfield Beach, Fla.), 2018, Volume: 30, Issue:43 Topics: Amides; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Proteins; Ciprofloxacin; Disease Models, Animal; Drug Delivery Systems; Drug Design; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen-Ion Concentration; Lung Diseases; Mice; Micelles; Nanoparticles; Peritonitis; Polymers; Proof of Concept Study; Sepsis; Thiophenes	2018

Article

Year

Bioresponsive Nanoparticles Targeted to Infectious Microenvironments for Sepsis Management.

Advanced materials (Deerfield Beach, Fla.), 2018, Volume: 30, Issue:43

Topics: Amides; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Proteins; Ciprofloxacin; Disease Models, Animal; Drug Delivery Systems; Drug Design; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen-Ion Concentration; Lung Diseases; Mice; Micelles; Nanoparticles; Peritonitis; Polymers; Proof of Concept Study; Sepsis; Thiophenes

2018